Based on reporting by TechCrunch.
What happened
Anthropic operates a wet biology lab in the Bay Area and its head of life sciences confirmed ongoing lab work. In April the company bought stealth AI biotech Coefficient Bio and recently announced a joint drug‑discovery partnership with Novo Nordisk. It also launched a Life Sciences Verification Program to give vetted bio researchers access to its models and published reports on accelerating protein design and bimolecular modeling. Its alignment lead assigned greater than a 10% chance that AI could exterminate humanity within a decade, while CEO Dario Amodei called for industry slowdown and self‑regulation, and investor Chamath Palihapitiya publicly criticized the wet lab initiative.
AIBeat analysis
These developments could position Anthropic as a leading player in AI‑driven life‑science research, potentially accelerating drug discovery while also raising safety and governance concerns given the high existential risk estimates and calls for industry self‑regulation.